← All Aridis Pharmaceuticals, INC filings

Aridis Pharmaceuticals, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
ARDS
Aridis Pharmaceuticals, INC
8-K: Aridis Pharmaceuticals Secures $0.3 Million in Private Placement
Aridis Pharmaceuticals has entered into a securities purchase agreement to sell 4,271,429 shares of common stock at $0.070 per share, raising approximately $0.30 million.
OTC.Pink
ARDS
Aridis Pharmaceuticals, INC
8-K: Aridis Pharmaceuticals Holds Annual Meeting, Elects Director and Approves Key Proposals
Aridis Pharmaceuticals held its annual meeting on January 12, 2024, where stockholders elected a director, ratified the appointment of an accounting firm, approved executive compensation, and approved the 2023 Omnibus Equity Incentive Plan.